4D Molecular Therapeutics
2 clinical trials · 2 recruiting · INDUSTRY
Trials by 4D Molecular Therapeutics
RECRUITINGPhase 1 / Phase 2NCT05629559
4D-310 in Adults With Fabry Disease and Cardiac Involvement
This is a prospective multicenter, open-label, dose-escalation trial to assess the safety, tolerability, and pharmacodynamics of 4D-310 following a single IV administration. The...
Sponsor: 4D Molecular TherapeuticsEnrolling: 184 locations
Fabry Disease
RECRUITINGPhase 3NCT07064759
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related...
A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration
Sponsor: 4D Molecular TherapeuticsEnrolling: 48020 locations
Neovascular Age-Related Macular Degeneration (nAMD)